Eklund M - Search Results

1

Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality-Reply.

Björnebo L, Eklund M, Lantz A. Björnebo L, et al. Among authors: eklund m. JAMA Oncol. 2022 Oct 13. doi: 10.1001/jamaoncol.2022.4792. Online ahead of print. JAMA Oncol. 2022. PMID: 36227621 No abstract available.

2

Response to Walsh.

Ström P, Lantz AW, Grönberg H, Nordström T, Eklund M. Ström P, et al. Among authors: eklund m. J Natl Cancer Inst. 2019 Jul 1;111(7):748. doi: 10.1093/jnci/djy187. J Natl Cancer Inst. 2019. PMID: 30380079 No abstract available.

3

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer.

Olsson H, Nordström T, Clements M, Grönberg H, Lantz AW, Eklund M. Olsson H, et al. Among authors: eklund m. Eur Urol Oncol. 2020 Oct;3(5):640-647. doi: 10.1016/j.euo.2019.05.005. Epub 2019 Jun 22. Eur Urol Oncol. 2020. PMID: 31235395 Free article.

4

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.

Beckmann K, Crawley D, Nordström T, Aly M, Olsson H, Lantz A, Binti Abd Jalal N, Garmo H, Adolfsson J, Eklund M, Van Hemelrijck M. Beckmann K, et al. Among authors: eklund m. JAMA Netw Open. 2019 Nov 1;2(11):e1914689. doi: 10.1001/jamanetworkopen.2019.14689. JAMA Netw Open. 2019. PMID: 31693126 Free PMC article.

5

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer.

Björnebo L, Olsson H, Nordström T, Jäderling F, Grönberg H, Eklund M, Lantz A. Björnebo L, et al. Among authors: eklund m. World J Urol. 2021 Jun;39(6):1797-1804. doi: 10.1007/s00345-020-03394-7. Epub 2020 Jul 30. World J Urol. 2021. PMID: 32734463 Free PMC article.

6

External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.

Salim M, Wåhlin E, Dembrower K, Azavedo E, Foukakis T, Liu Y, Smith K, Eklund M, Strand F. Salim M, et al. Among authors: eklund m. JAMA Oncol. 2020 Oct 1;6(10):1581-1588. doi: 10.1001/jamaoncol.2020.3321. JAMA Oncol. 2020. PMID: 32852536 Free PMC article.

7

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS).

Olsson H, Nordström T, Jäderling F, Egevad L, Vigneswaran HT, Annerstedt M, Grönberg H, Eklund M, Lantz A. Olsson H, et al. Among authors: eklund m. J Natl Cancer Inst. 2021 May 4;113(5):632-640. doi: 10.1093/jnci/djaa131. J Natl Cancer Inst. 2021. PMID: 32866231 Free PMC article. Clinical Trial.

8

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality.

Björnebo L, Nordström T, Discacciati A, Palsdottir T, Aly M, Grönberg H, Eklund M, Lantz A. Björnebo L, et al. Among authors: eklund m. JAMA Oncol. 2022 Jul 1;8(7):1019-1026. doi: 10.1001/jamaoncol.2022.1501. JAMA Oncol. 2022. PMID: 35587340 Free PMC article.

9

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening.

Andersson J, Palsdottir T, Lantz A, Aly M, Grönberg H, Egevad L, Eklund M, Nordström T. Andersson J, et al. Among authors: eklund m. Eur Urol Open Sci. 2022 Aug 29;44:69-75. doi: 10.1016/j.euros.2022.08.006. eCollection 2022 Oct. Eur Urol Open Sci. 2022. PMID: 36185581 Free PMC article.

10

Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.

Wallerstedt A, Strom P, Gronberg H, Nordstrom T, Eklund M. Wallerstedt A, et al. Among authors: eklund m. J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036. J Natl Cancer Inst. 2018. PMID: 29548030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page